Activist investor Nelson Peltz stepped up his fight to break up the company, as his Trian Fund nominated himself and three other members to the board.» Read More
Cramer makes the call on viewers' favorite stocks.
Time to face the foul facts, America. To profit amid our economic pain you may have no choice but to dive headlong into the muck.
In Wednesday’s Web Extra the traders take their positions ahead of Chesapeake Energy and Procter & Gamble earnings.
Plus, Intel drags down tech, breaking news from American Airlines and UPS and much more.
Following are the day's biggest winners and losers. Find out why shares of Illumina popped while Posco dropped and more.
Most analysts believe the market is due for a modest correction, but many traders are reluctant to sell in the face of strong earnings, massive liquidity and daily deals. "I don't think there's anything to be that bearish about," Stephen Leeb, research chairman for The Complete Investor, told CNBC.com. "There's no recession, valuations are basically very reasonable and there are massive amounts of cash on the sidelines."
Here’s the final trade: our guys give you tomorrow's best trades tonight.
Jeff from California asked whether Healthcare is an essential sector to own for diversification or are there other "recession-proof" sectors that can take it's place, since biotech is dicey and big pharma's pipeline is weak?